Xilio Therapeutics, Inc.
XLO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $55 | $45 | $120 | $198 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | $0 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $5 | $3 | $4 | $4 |
| Total Curr. Assets | $60 | $48 | $124 | $203 |
| Property Plant & Equip (Net) | $9 | $11 | $13 | $14 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $2 | $0 | $2 | $2 |
| Tax Assets | $0 | $0 | $0 | $4 |
| Other NC Assets | $0 | $2 | $0 | $0 |
| Total NC Assets | $11 | $13 | $15 | $19 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $71 | $61 | $139 | $222 |
| Liabilities | – | – | – | – |
| Payables | $3 | $1 | $3 | $3 |
| Short-Term Debt | $1 | $3 | $8 | $1 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $14 | $0 | $0 | $0 |
| Other Curr. Liab. | $10 | $12 | $10 | $9 |
| Total Curr. Liab. | $27 | $16 | $21 | $13 |
| LT Debt | $7 | $8 | $12 | $20 |
| Deferred Rev, NC | $19 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $4 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $26 | $8 | $12 | $23 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $8 | $8 | $10 | $10 |
| Total Liabilities | $53 | $24 | $34 | $36 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$384 | -$326 | -$249 | -$161 |
| AOCI | $0 | $0 | $0 | $0 |
| Other Equity | $401 | $362 | $355 | $346 |
| Total Equity | $18 | $37 | $106 | $185 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $71 | $61 | $139 | $222 |
| Net Debt | -$47 | -$33 | -$100 | -$177 |